Myositis associated with graft-versus-host disease

Current Opinion in Rheumatology

Volumn 9, Issue 6, 1997, Pages 513-519

  Parker, Pablo M ^a   Openshaw, Harry ^a   Forman, Stephen J ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; PREDNISONE;

ALLOGENIC BONE MARROW TRANSPLANTATION; AUTOIMMUNITY; BONE MARROW; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; MYOSITIS; POLYMYOSITIS; PRIORITY JOURNAL; REVIEW;

EID: 0030809898     PISSN: 10408711     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002281-199711000-00006     Document Type: Review

References (59)

1. Parker P, Chao N, Ben-Ezra J, Slatkin N, Openshaw H, Niland JC, Linker CA, Greffe BS, Kashyap A, Molina A, et al.: Polymyositis as a manifestation of chronic graft-versus-host disease. Medicine 1996, 75:279-285. A report of clinical and immune pathologic aspects of the largest collection (eleven cases) of GVH myositis.
2. Forman SJ, Blume KG, Thomas ED, eds: Bone Marrow Transplantation. Boston: Blackwell Scientific; 1994.
3. Billingham RE: The biology of graft-versus-host reactions. Harvey Lect 1966, 62:21-78.
4. Lazarus HM, Vogelsang GB, Rowe JM: Prevention and treatment of acute graft-versus-host disease: the old and the new. A report from the Eastern Cooperative Oncology Group (ECOG). Bone Marrow Transplant 1997, 19:577-600. A recent comprehensive review of immune pathology and treatment of GVHD.
5. Beatty PG: The use of unrelated donors for bone marrow transplantation. Marrow Transplant Rev 1991, 1:1,3-6.
6. Morishima Y, Morishita Y, Tanimoto M, Ohno R, Hidehiko S, Horibe K, Hamahima N, Naito K, Yamada K, Yokomaku S, et al., and the Nagoya Bone Marrow Transplantation Group: Low incidence of acute graft-versus-host disease by the administration of methotrexate and cyclosporine in Japanese leukemia patients after bone marrow transplantation from human leukocyte antigen compatible siblings: possible role of genetic homogeneity, xxx 1989, 74:2252-2256.
7. Sullivan KM, Deeg HJ, Sanders J, Klosterman A, Amos D, Shulman H, Sale G, Martin P, Witherspoon R, Appelbaum F, et al.: Hyperacute graft-v-host disease in patients not given immunosuppression after allogeneic marrow transplantation. Blood 1986, 67:1172-1175.
8. Powles R, Pedrazzini A, Crofts M, Clink H, Millar J, Bhattia G, Perez D: Mismatched family bone marrow transplantation. Semin Hematol 1984, 21:182-187.
9. Holler E, Kolb HJ, Hiller E: Microangiopathy in patients on cyclosporine prophylaxis who developed acute graft-versus-host disease after HLA-identical bone marrow transplantation. Blood 1989, 73:2018-2024.
10. Jabs DA, Wingard J, Green RW, Farmer ER, Vogelsang G, Saral R: The eye in bone marrow transplantation. Arch Ophthalmol 1989, 107:1343-1348.
11. Nelson KR, McQuillen MP: Neurologic complications of graft-versus-host disease. Neurol Clin 1988, 6:389-403.
12. Smith CIE, Aarli JA, Biberfeld P, Bolme P, Christensson B, Gahrton G, Hammarstrom L, Lefvert AK, Lonnqvist B, Matell G, et al.: Myasthenia gravis after bone marrow transplantation. N Engl J Med 1983, 309:1565-1568.
13. Bolger GB, Sullivan KM, Spencer AM: Myasthenia gravis after allogeneic bone marrow transplantation: relationship to chronic graft-versus-host disease. Neurology 1986, 36:1087-1091.
14. Openshaw H, Slatkin N, Parker P, Forman SJ: Immune-mediated myelopathy after allogeneic marrow transplantation. Bone Marrow Transplant 1995, 15:633-636.
15. Openshaw H, Slatkin N: Differential diagnosis of neurological complications in bone marrow transplantation. Neurologist 1995, 1:191-206. Reviews polymyositis, myasthenia, and inflammatory polyneuropathy in patients with GVHD.
16. Amato AA, Barohn RH, Sahenk RJ, Tutschka PJ, Mendell JR: Polyneuropathy complicating bone marrow and solid organ transplantation. Neurology 1993, 43:1513-1517.
17. Anasetti C, Rybka W, Sullivan KM, Banaji M, Slichter SJ: Graft-v-host disease is associated with autoimmune-like thrombocytopenla. Blood 1989, 73:1054-1058.
18. Atkison K: Chronic graft-versus-host disease. Bone Marrow Transplant 1990, 5:69-82.
19. Saurat JH: Cutaneous manifestations of graft-versus-host disease, Int J Dermatol 1981, 4:249-256.
20. Shulman HM, Sale GE, Lerner KG, Barker EA, Weiden PL, Sullivan K, Gatlucci B, Thomas ED: Chronic cutaneous graft-versus-host disease in man. Am J Pathol 1978, 91:545-570.
21. Lawley TJ, Peck GL, Moutsopoulos HM, Gratwohl AA, Deisseroth AB: Scleroderma, Sjögren-like syndrome, and chronic graft-versus-host disease. Ann Intern Med 1977, 87:707-709.
22. Sullivan KM, Shulman, Storb R, Weiden PL, Witherspoon RP, McDonald GB, Schubert MM, Atkinson K, Thomas ED: Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression. Blood 1981, 57:267-276.
23. Epstein O, Thomas HC, Sherlock S: Primary biliary cirrhosis is a dry gland syndrome with features of chronic graft-versus-host disease. Lancet 1980, 1:1166-1168.
24. Graze PR, Gale RP: Chronic graft-versus-host disease: a syndrome of disordered immunity. Am J Med 1979, 66:611-620.
25. Lister J, Messner H, Keyston E, Miller R, Fritzler MJ: Autoantibody analysis of patients with graft versus host disease. J Clin Lab Immunol 1987, 24:19-23.
26. Rouquette-Gally AM, Boyeldieu D, Prost AC, Gluckman E: Autoimmunity after allogeneic bone marrow transplantation. Transplantation 1988, 46:238-240.
27. Tazzari PL, Gobbi M, Zauli D, Tassinari A, Crespi C, Miserocchi F, Dinota A, Bandini G, Ricci P, Tura S: Close association between antibodies to cytoskeletal intermediate filaments, and chronic graft-versus-host disease. Transplantation 1987, 44:234-236.
28. Dighiero G, Intrator L, Cordonnier C, Tortevoye P, Vernant J-P: High levels of anti-cytoskeleton auto antibodies are frequently associated with chronic GVHD. Br J Haematol 1987, 67:301-305.
29. Kier P, Penner E, Bakos S, Kalhs P, Lechner K, Volc-Platzer B, Wesierska-Gadek J, Sauermann G, Gadner H, Emminger-Schmidmeir W, Hinterberger W: Autoantibodies chronic GVHD: high prevalence of antinucleolar antibodies. Bone Marrow Transplant 1990, 6:93-96.
30. Beschorner WE, Tutschka PJ, Santos GW: Chronic graft-versus-host disease in the rat radiation chimera: I. Clinical features, hematology, histology, and immunopathology in long-term chimeras. Transplantation 1982, 33:393-399.
31. Tutschka PJ, Teasdall R, Beschorner WE, Santos GW: Chronic graft-versus-host disease in the rat radiation chimera. II: Immunological evaluation in long-term chimeras. Transplantation 1982, 34:289-294.
32. Atkinson K, Incefy GS, Storb R, Sullivan KM, Iwata T, Dardenne M, Ochs HD, Good RA, Thomas ED: Low serum thymic hormone levels in patients with chronic graft-versus-host disease. Blood 1982, 59:1073-1077.
33. Mackall CL, Fleisher TA, Brown MR, Andrich MP, Chen CC, Feuerstein IM, Morowitz ME, Magrath IT, Aziza TS, Steinberg SM, et al.: Age, thymopoiesis, and CD44 T-lymphocyte regeneration after intensive chemotherapy. N Engl J Med 1993, 332:143-149.
34. Weinberg K, Parkman R: Age, the thymus, and T lymphocytes. N Engl J Med 1993, 332:182-183.
35. Burakoff SJ, Deeg HJ, Ferrara J, Atkinson K, eds.: Graft-Versus-Host Disease: Immunology, Pathophysiology, and Treatment. New York: Marcel Dekker; 1990.
36. Weisdorf D, Hakke R, Blazar B, Miller W, McGlave P, Ramsay N, Kersey J, Filipovich A: Risk factors for acute graft-versus-host disease in histocompatible donor bone marrow transplantation. Transplantation 1991, 51:1197-1203.
37. Nash RA, Pep MS, Storb R, Longton G, Pettinger M, Anasetti C, Appelbaum FR, Bowden RA, Deeg HJ, Doney K, et al.: Acute graft-versus-host disease: analysis of risk factors after allogeneic marrow transplantation and prophylaxis with cyclosporine and methotrexate. Blood 1992, 80:1838-1845.
38. Sullivan KM, Agura E, Anasetti C, Appelbaum F, Badger C, Bearman S, Erickson K, Flowers M, Hansen J, Loughran T, et al.: Chronic graft-versus-host disease and other late complications of bone marrow transplantation. Semin Hematol 1991, 28:250-259.
39. Sullivan KM, Witherspoon RP, Storb R, Weiden P, Floumoy N, Dahlberg S, Deeg HJ, Sanders JE, Doney KC, Appelbaum FR, et al.: Prednisone and azathioprine compared with prednisone and placebo for treatment of chronic graft-versus-host disease: prognostic influence of prolonged thrombocytopenia after allogeneic marrow transplantation. Blood 1988, 72:546-554.
40. Sullivan KM, Mori M, Witherspoon R, Sanders J, Appelbaum FR, Storb R: Alternating-day cyclosporine and prednisone (CSP/PRED) treatment of chronic graft-versus-host disease (GVHD): predictors of survival [abstract]. Stood 1990, 76:568a.
41. Parker PM, Chao N, Nademanee A, O'Donnell MR, Schmidt GM, Snyder DS, Stein AS, Smith EP, Molina A, Stepan DE, et al.: Thalidomide as salvage therapy for chronic graft versus host disease, Blood 1995, 86:3604-3609.
42. Sieber F: Phototherapy, photochemotherapy, and bone marrow transplantation. J Hematother 1993, 2:43-62.
43. Pruzzick R, Brain MC, Walker IR, Sauder DN: Polymyositis: a manifestation of chronic graft-versus-host disease. J Am Acad Dermatol 1991, 25:560-562.
44. Ascensao JL, Mascarenhas RB, Mittelman A, Ahmed T: Case report: acute polymyositis in a patient with chronic graft vs. host disease. Med Oncol Tumor Pharmacother 1992, 9:149-150.
45. Hanslik T, Jaccard A, Guillon JM, Vernant JP, Wechsler B, Godeau P: Polymyositis and chronic graft-versus-host disease: efficacy of intravenous gammaglobulin. J Am Acad Dermatol 1993, 28:492-493.
46. Blanche P, Dreyfus F, Sicard D: Polymyositis and chronic graft versus host disease: efficacy of intravenous gammaglobulin and methotrexate. Clin Exp Rheumatol 1995, 13:377-379. The most recently reported cases of GVHD myositis.
47. Reyes MG, Noronha P, Thomas W, Heredia R: Myositis of chronic graft versus host disease. Neurology 1983, 33:122-124.
48. Anderson BA, Young V, Kean WF, Ludwin Sk, Galbraith PR, Anastassiades TP: Polymyositis in chronic graft vs host disease. Arch Neurol 1982, 39:188-190.
49. Engel AG, Arahata K: Mononuclear cells in myopathies: quantitation of functionally distinct subsets, recognition of antigen-specific cell mediated cytotoxicity in some disease, and implications for the pathogenesis of the different inflammatory myopathies. Hum Pathol 1986, 17:704-721.
50. Plotz PH, Rider LG, Targoff IN, Raben N, O'Hanlon TP, Miller FW: Myositis: immunologic contributions to understanding cause, pathogenesis, and therapy. Ann Intern Med 1995, 122:715-724. Excellent discussion of this subject.
51. Khaleeli AA, Edwards RHT, Gohil K, McPhail G, Rennie MJ, Round J, Ross EJ: Corticosteroid myopathy: a clinical and pathological study. Clin Edocrinol 1983, 18:155-166.
52. Dalakas MC: Polymyositis, dermatomyositis, and inclusion-body myositis. N Engl J Med 1991, 325:1487-1498.
53. Urbano-Marquez A, Estruch R, Grau JM, Granena A, Martin-Ortega E, Palou J, Rozman C: Inflammatory myopathy associated with graft versus host disease. Neurology 1986, 36:1091-1093.
54. Mulligan SP, Joshua DE, Joasoo A, Kronenberg H: Autoimmune hyper-thyroidism associated with chronic graft-versus-host disease. Transplantation 1987, 44:463-464.
55. Zochodne DW, Ramsay DA, Saly V, Shelly S, Moffat S: Acute necrotizing myopathy of intensive care: electrophysiologic studies. Muscle Nerve 1994, 17:285-292.
56. Lacomis D, Giuliani MJ, VanCott A, Kramer DJ: Acute myopathy of intensive care: clinical, electromyographic and pathologic aspects. Ann Neurol 1996, 40:645-654.
57. Volin L, Jarventie G, Ruutu T: Fatal rhabdomyolysis as a complication of bone marrow transplantation. Bone Marrow Transplant 1990, 6:59-60.
58. Sandrock AW, Cros DP, Louis DN: A 51-year-old man with chronic obstructive pulmonary disease and generalized muscle weakness. N Engl J Med 1997, 336:1079-1088.
59. Sullivan KM, Witherspoon RP, Storb R, Deeg HJ, Dahlberg S, Sanders JE, Appelbaum FR, Doney KC, Weiden P, Anasetti C: Alternating-day cyclosporine and prednisone for treatment of high-risk chronic graft versus host disease. Blood 1988, 72:555-561.